Along with the challenges of access to health technologies to address the burden of communicable disease, low- and middle-income countries are also increasingly grappling with the rising burdens of non-communicable diseases. Yet newer, patented treatments often carry price tags that are not affordable for the vast majority of patients in low- and middle-income countries. Taking a closer look at the growing interest in niche markets and personalized medicine”, World Medical and Health Policy, vol.